Literature DB >> 11692305

The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis.

M Cruciani1, M Malena, O Bosco, G Gatti, G Serpelloni.   

Abstract

To assess if the relative infectiousness of patients with tuberculosis is enhanced by coinfection with human immunodeficiency virus type 1 (HIV-1), data from 6 studies of 1240 health care workers who had contact with tuberculosis patients were analyzed. Overall rates of tuberculin skin test conversion were similar regardless of HIV-1 positivity of tuberculosis patients (odds ratio [OR], 1.04; 95% confidence interval [CI], 0.23-1.84). However, when only 3 studies during nosocomial outbreaks of multidrug-resistant Mycobacterium tuberculosis were analyzed, rates of skin test conversion were higher among contacts of HIV-1-positive index cases (OR, 2.85; 95% CI, 1.85-3.85; P=.0002). A second meta-analysis included data from 11 studies of 10,714 household contacts of tuberculosis patients. Prevalence of both skin test positivity (OR, 0.45; 95% CI, 0.20-1.03) and active disease (OR, 1.17; 95% CI, 0.78-1.56) were similar regardless of HIV-1 positivity of index cases. These data suggest that tuberculosis patients with HIV-1 infection are not intrinsically more infectious to their contacts than are HIV-1-negative tuberculosis patients.

Entities:  

Mesh:

Year:  2001        PMID: 11692305     DOI: 10.1086/324352

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

1.  Current and future trends in tuberculosis incidence in New York City: a dynamic modelling analysis.

Authors:  Anthony T Fojo; Natalie L Stennis; Andrew S Azman; Emily A Kendall; Sourya Shrestha; Shama D Ahuja; David W Dowdy
Journal:  Lancet Public Health       Date:  2017-07

Review 2.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Integrating social contact and environmental data in evaluating tuberculosis transmission in a South African township.

Authors:  Jason R Andrews; Carl Morrow; Rochelle P Walensky; Robin Wood
Journal:  J Infect Dis       Date:  2014-03-08       Impact factor: 5.226

Review 4.  Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings.

Authors:  Julian S Peters; Jason R Andrews; Mark Hatherill; Sabine Hermans; Leonardo Martinez; Erwin Schurr; Yuri van der Heijden; Robin Wood; Roxana Rustomjee; Bavesh D Kana
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

Review 5.  Old and new selective pressures on Mycobacterium tuberculosis.

Authors:  Daniela Brites; Sebastien Gagneux
Journal:  Infect Genet Evol       Date:  2011-08-17       Impact factor: 3.342

6.  Area-level socioeconomic disadvantage and severe pulmonary tuberculosis: U.S., 2000-2008.

Authors:  Eyal Oren; Masahiro Narita; Charles Nolan; Jonathan Mayer
Journal:  Public Health Rep       Date:  2013 Mar-Apr       Impact factor: 2.792

Review 7.  Infectious Diseases of Poverty in Children: A Tale of Two Worlds.

Authors:  Caitlin Hansen; Elijah Paintsil
Journal:  Pediatr Clin North Am       Date:  2016-02       Impact factor: 3.278

8.  The tuberculosis challenge in a rural South African HIV programme.

Authors:  Catherine F Houlihan; Portia C Mutevedzi; Richard J Lessells; Graham S Cooke; Frank C Tanser; Marie-Louise Newell
Journal:  BMC Infect Dis       Date:  2010-02-10       Impact factor: 3.090

9.  The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts.

Authors:  Chuan-Chin Huang; Eric Tchetgen Tchetgen; Mercedes C Becerra; Ted Cohen; Katherine C Hughes; Zibiao Zhang; Roger Calderon; Rosa Yataco; Carmen Contreras; Jerome Galea; Leonid Lecca; Megan Murray
Journal:  Clin Infect Dis       Date:  2013-12-23       Impact factor: 9.079

10.  Infectiousness of HIV-Seropositive Patients with Tuberculosis in a High-Burden African Setting.

Authors:  Leonardo Martinez; Juliet N Sekandi; María E Castellanos; Sarah Zalwango; Christopher C Whalen
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.